Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Prodrug). Showing records 1 – 30 of 139 total matches.

[1] [2] [3] [4] [5]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Country

▼ Search Limiters


University of Colorado

1. Rudnicki, Daniel Lee. Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine.

Degree: PhD, Chemistry & Biochemistry, 2012, University of Colorado

  Doxorubicin (Dox) is an antitumor drug that has been used as a chemotherapeutic agent in the clinic for over 30 years. Dox treatments have… (more)

Subjects/Keywords: Anthracycline; Cancer; Prodrug; Chemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rudnicki, D. L. (2012). Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine. (Doctoral Dissertation). University of Colorado. Retrieved from https://scholar.colorado.edu/chem_gradetds/61

Chicago Manual of Style (16th Edition):

Rudnicki, Daniel Lee. “Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine.” 2012. Doctoral Dissertation, University of Colorado. Accessed April 11, 2021. https://scholar.colorado.edu/chem_gradetds/61.

MLA Handbook (7th Edition):

Rudnicki, Daniel Lee. “Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine.” 2012. Web. 11 Apr 2021.

Vancouver:

Rudnicki DL. Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine. [Internet] [Doctoral dissertation]. University of Colorado; 2012. [cited 2021 Apr 11]. Available from: https://scholar.colorado.edu/chem_gradetds/61.

Council of Science Editors:

Rudnicki DL. Targeted Prodrugs of a Novel Platform Anthracycline: Doxazolidine. [Doctoral Dissertation]. University of Colorado; 2012. Available from: https://scholar.colorado.edu/chem_gradetds/61


Victoria University of Wellington

2. Li, Ye. Design and Synthesis of Antiviral Iminoribitol C-Nucleosides.

Degree: 2017, Victoria University of Wellington

 Infections caused by RNA viruses, such as Ebola and Zika, continue to exist worldwide as significant public health problems. In response to the urgent need… (more)

Subjects/Keywords: Iminoribitol; Immucillins; Prodrug; ProTides

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Li, Y. (2017). Design and Synthesis of Antiviral Iminoribitol C-Nucleosides. (Masters Thesis). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/9098

Chicago Manual of Style (16th Edition):

Li, Ye. “Design and Synthesis of Antiviral Iminoribitol C-Nucleosides.” 2017. Masters Thesis, Victoria University of Wellington. Accessed April 11, 2021. http://hdl.handle.net/10063/9098.

MLA Handbook (7th Edition):

Li, Ye. “Design and Synthesis of Antiviral Iminoribitol C-Nucleosides.” 2017. Web. 11 Apr 2021.

Vancouver:

Li Y. Design and Synthesis of Antiviral Iminoribitol C-Nucleosides. [Internet] [Masters thesis]. Victoria University of Wellington; 2017. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/10063/9098.

Council of Science Editors:

Li Y. Design and Synthesis of Antiviral Iminoribitol C-Nucleosides. [Masters Thesis]. Victoria University of Wellington; 2017. Available from: http://hdl.handle.net/10063/9098


University of Sydney

3. Tondl, Elisabeth Michelle. Modulating prodrug selectivity for prostate cancer: Design, synthesis, and testing of a modified peptide vehicle .

Degree: 2020, University of Sydney

 Precision oncology approaches in prostate cancer treatment offer a complementary approach to genomics by targeting molecular phenotypes of an individual’s cancer, such as membrane transporter… (more)

Subjects/Keywords: prostate cancer; prodrug; peptide; selectivity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tondl, E. M. (2020). Modulating prodrug selectivity for prostate cancer: Design, synthesis, and testing of a modified peptide vehicle . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/24553

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tondl, Elisabeth Michelle. “Modulating prodrug selectivity for prostate cancer: Design, synthesis, and testing of a modified peptide vehicle .” 2020. Thesis, University of Sydney. Accessed April 11, 2021. http://hdl.handle.net/2123/24553.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tondl, Elisabeth Michelle. “Modulating prodrug selectivity for prostate cancer: Design, synthesis, and testing of a modified peptide vehicle .” 2020. Web. 11 Apr 2021.

Vancouver:

Tondl EM. Modulating prodrug selectivity for prostate cancer: Design, synthesis, and testing of a modified peptide vehicle . [Internet] [Thesis]. University of Sydney; 2020. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/2123/24553.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tondl EM. Modulating prodrug selectivity for prostate cancer: Design, synthesis, and testing of a modified peptide vehicle . [Thesis]. University of Sydney; 2020. Available from: http://hdl.handle.net/2123/24553

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

4. Soraya da Silva Santos. Antichagásicos e leishmanicidas potenciais: estudo das condições de síntese de pró-fármacos dendriméricos de 3-hidroxiflavona.

Degree: 2016, University of São Paulo

INTRODUÇÃO: A doença de Chagas e a leishmaniose são doenças tropicais supernegligenciadas, que afetam regiões de extrema pobreza. Os fármacos disponíveis para estas duas doenças… (more)

Subjects/Keywords: Dendrímeros; Flavonóides; Latenciação; Pró-fármacos; Dendrimer; Flavonoid; Prodrug; Prodrug design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santos, S. d. S. (2016). Antichagásicos e leishmanicidas potenciais: estudo das condições de síntese de pró-fármacos dendriméricos de 3-hidroxiflavona. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/9/9138/tde-07122016-084358/

Chicago Manual of Style (16th Edition):

Santos, Soraya da Silva. “Antichagásicos e leishmanicidas potenciais: estudo das condições de síntese de pró-fármacos dendriméricos de 3-hidroxiflavona.” 2016. Doctoral Dissertation, University of São Paulo. Accessed April 11, 2021. http://www.teses.usp.br/teses/disponiveis/9/9138/tde-07122016-084358/.

MLA Handbook (7th Edition):

Santos, Soraya da Silva. “Antichagásicos e leishmanicidas potenciais: estudo das condições de síntese de pró-fármacos dendriméricos de 3-hidroxiflavona.” 2016. Web. 11 Apr 2021.

Vancouver:

Santos SdS. Antichagásicos e leishmanicidas potenciais: estudo das condições de síntese de pró-fármacos dendriméricos de 3-hidroxiflavona. [Internet] [Doctoral dissertation]. University of São Paulo; 2016. [cited 2021 Apr 11]. Available from: http://www.teses.usp.br/teses/disponiveis/9/9138/tde-07122016-084358/.

Council of Science Editors:

Santos SdS. Antichagásicos e leishmanicidas potenciais: estudo das condições de síntese de pró-fármacos dendriméricos de 3-hidroxiflavona. [Doctoral Dissertation]. University of São Paulo; 2016. Available from: http://www.teses.usp.br/teses/disponiveis/9/9138/tde-07122016-084358/

5. Wright, Robert Clay. ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY.

Degree: 2014, Johns Hopkins University

 Prevailing approaches for developing cancer protein therapeutics focus on creating proteins that therapeutically modulate a cancer marker’s function. Such an approach limits the therapeutic mechanism… (more)

Subjects/Keywords: Enzyme Prodrug Therapy; Protein Engineering; Cancer Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wright, R. C. (2014). ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37975

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wright, Robert Clay. “ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY.” 2014. Thesis, Johns Hopkins University. Accessed April 11, 2021. http://jhir.library.jhu.edu/handle/1774.2/37975.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wright, Robert Clay. “ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY.” 2014. Web. 11 Apr 2021.

Vancouver:

Wright RC. ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2021 Apr 11]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37975.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wright RC. ADVANCES IN THE DEVELOPMENT OF HIF-1α-ACTIVATED PROTEIN SWITCHES FOR ENZYME PRODRUG THERAPY. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37975

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Iowa

6. Shippy, Rebekah Ruth. Synthesis of phosphoantigens and chiral trisphosphonates.

Degree: PhD, Chemistry, 2016, University of Iowa

  Phosphorus is an element that is essential for life, and is used in the synthesis of many proteins, carbohydrates and deoxyribonucleic acids. Phosphorus often… (more)

Subjects/Keywords: Fluorescent; Phosphoanitgens; Phosphonates; Prodrug; Trisphosphonates; Chemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shippy, R. R. (2016). Synthesis of phosphoantigens and chiral trisphosphonates. (Doctoral Dissertation). University of Iowa. Retrieved from https://ir.uiowa.edu/etd/5632

Chicago Manual of Style (16th Edition):

Shippy, Rebekah Ruth. “Synthesis of phosphoantigens and chiral trisphosphonates.” 2016. Doctoral Dissertation, University of Iowa. Accessed April 11, 2021. https://ir.uiowa.edu/etd/5632.

MLA Handbook (7th Edition):

Shippy, Rebekah Ruth. “Synthesis of phosphoantigens and chiral trisphosphonates.” 2016. Web. 11 Apr 2021.

Vancouver:

Shippy RR. Synthesis of phosphoantigens and chiral trisphosphonates. [Internet] [Doctoral dissertation]. University of Iowa; 2016. [cited 2021 Apr 11]. Available from: https://ir.uiowa.edu/etd/5632.

Council of Science Editors:

Shippy RR. Synthesis of phosphoantigens and chiral trisphosphonates. [Doctoral Dissertation]. University of Iowa; 2016. Available from: https://ir.uiowa.edu/etd/5632


University of Manitoba

7. Liang, Dinghua. Progress towards hypoxia-activated SN-38: the potential to target hypoxic tumors.

Degree: Pharmacy, 2015, University of Manitoba

 Solid tumors are commonly subject to hypoxia. Hypoxic cancer cells have undesirable properties such as a high tendency to metastasize and resistance to chemotherapy and… (more)

Subjects/Keywords: Hypoxia; Prodrug; Targeted chemotherapy; Bioreductive; Antineoplastic agents

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Liang, D. (2015). Progress towards hypoxia-activated SN-38: the potential to target hypoxic tumors. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/31591

Chicago Manual of Style (16th Edition):

Liang, Dinghua. “Progress towards hypoxia-activated SN-38: the potential to target hypoxic tumors.” 2015. Masters Thesis, University of Manitoba. Accessed April 11, 2021. http://hdl.handle.net/1993/31591.

MLA Handbook (7th Edition):

Liang, Dinghua. “Progress towards hypoxia-activated SN-38: the potential to target hypoxic tumors.” 2015. Web. 11 Apr 2021.

Vancouver:

Liang D. Progress towards hypoxia-activated SN-38: the potential to target hypoxic tumors. [Internet] [Masters thesis]. University of Manitoba; 2015. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/1993/31591.

Council of Science Editors:

Liang D. Progress towards hypoxia-activated SN-38: the potential to target hypoxic tumors. [Masters Thesis]. University of Manitoba; 2015. Available from: http://hdl.handle.net/1993/31591


University of Minnesota

8. Rautiola, Davin. Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines.

Degree: PhD, Pharmaceutics, 2019, University of Minnesota

 A seizure emergency occurs when an individual experiences a seizure that lasts for more than five minutes (status epilepticus) or multiple distinct seizures with incomplete… (more)

Subjects/Keywords: benzodiazepines; intranasal; metastable; prodrug; solubility; supersaturated

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rautiola, D. (2019). Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/208986

Chicago Manual of Style (16th Edition):

Rautiola, Davin. “Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines.” 2019. Doctoral Dissertation, University of Minnesota. Accessed April 11, 2021. http://hdl.handle.net/11299/208986.

MLA Handbook (7th Edition):

Rautiola, Davin. “Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines.” 2019. Web. 11 Apr 2021.

Vancouver:

Rautiola D. Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines. [Internet] [Doctoral dissertation]. University of Minnesota; 2019. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/11299/208986.

Council of Science Editors:

Rautiola D. Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines. [Doctoral Dissertation]. University of Minnesota; 2019. Available from: http://hdl.handle.net/11299/208986


Louisiana State University

9. Batton, Chyree Shantel. Synthetic Routes to Therapeutic Agents Via Masked Functionalities: From Orthogonal Peptide Crosslink to Photothermal Cancer Prodrug.

Degree: PhD, Chemistry, 2014, Louisiana State University

 The theonellamides are a family of compounds distinguished by their crosslinking ô-histidinoalanine (ô-HAL) residue. Part one of this dissertation details the synthesis of an orthogonally… (more)

Subjects/Keywords: Histidinoalanine; GUMBOS; nanoparticles; photothermal; prodrug; orthogonal

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Batton, C. S. (2014). Synthetic Routes to Therapeutic Agents Via Masked Functionalities: From Orthogonal Peptide Crosslink to Photothermal Cancer Prodrug. (Doctoral Dissertation). Louisiana State University. Retrieved from etd-11172014-152711 ; https://digitalcommons.lsu.edu/gradschool_dissertations/1176

Chicago Manual of Style (16th Edition):

Batton, Chyree Shantel. “Synthetic Routes to Therapeutic Agents Via Masked Functionalities: From Orthogonal Peptide Crosslink to Photothermal Cancer Prodrug.” 2014. Doctoral Dissertation, Louisiana State University. Accessed April 11, 2021. etd-11172014-152711 ; https://digitalcommons.lsu.edu/gradschool_dissertations/1176.

MLA Handbook (7th Edition):

Batton, Chyree Shantel. “Synthetic Routes to Therapeutic Agents Via Masked Functionalities: From Orthogonal Peptide Crosslink to Photothermal Cancer Prodrug.” 2014. Web. 11 Apr 2021.

Vancouver:

Batton CS. Synthetic Routes to Therapeutic Agents Via Masked Functionalities: From Orthogonal Peptide Crosslink to Photothermal Cancer Prodrug. [Internet] [Doctoral dissertation]. Louisiana State University; 2014. [cited 2021 Apr 11]. Available from: etd-11172014-152711 ; https://digitalcommons.lsu.edu/gradschool_dissertations/1176.

Council of Science Editors:

Batton CS. Synthetic Routes to Therapeutic Agents Via Masked Functionalities: From Orthogonal Peptide Crosslink to Photothermal Cancer Prodrug. [Doctoral Dissertation]. Louisiana State University; 2014. Available from: etd-11172014-152711 ; https://digitalcommons.lsu.edu/gradschool_dissertations/1176


University of Georgia

10. Israel, Bridg'ette Beatrice. Topical formulations for disease treatment.

Degree: 2014, University of Georgia

 Purpose: Develop a bioadhesive formulation for the treatment of aquatic life with skin lesions or abrasions. The purpose of the second research project is to… (more)

Subjects/Keywords: Bioadhesion; Oleaginous; Transdermal Permeation; Mutual Prodrug; NSAID

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Israel, B. B. (2014). Topical formulations for disease treatment. (Thesis). University of Georgia. Retrieved from http://hdl.handle.net/10724/26359

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Israel, Bridg'ette Beatrice. “Topical formulations for disease treatment.” 2014. Thesis, University of Georgia. Accessed April 11, 2021. http://hdl.handle.net/10724/26359.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Israel, Bridg'ette Beatrice. “Topical formulations for disease treatment.” 2014. Web. 11 Apr 2021.

Vancouver:

Israel BB. Topical formulations for disease treatment. [Internet] [Thesis]. University of Georgia; 2014. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/10724/26359.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Israel BB. Topical formulations for disease treatment. [Thesis]. University of Georgia; 2014. Available from: http://hdl.handle.net/10724/26359

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Ball, Patrick. Identification and testing of enzymes and prodrugs for use in directed enzyme prodrug therapy strategies for the treatment of cancer.

Degree: PhD, 2019, Bangor University

 Cancer is one of the leading causes of death worldwide and improving the efficacy of cancer chemotherapy treatments is one of the most pressing issues… (more)

Subjects/Keywords: 500; Nitroreductase; Prodrug; Cancer; Dept; HPCC

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ball, P. (2019). Identification and testing of enzymes and prodrugs for use in directed enzyme prodrug therapy strategies for the treatment of cancer. (Doctoral Dissertation). Bangor University. Retrieved from https://research.bangor.ac.uk/portal/en/theses/identification-and-testing-of-enzymes-and-prodrugs-for-use-in-directed-enzyme-prodrug-therapy-strategies-for-the-treatment-of-cancer(c07f9470-fc01-4ef9-8e23-426f320c3abd).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.793161

Chicago Manual of Style (16th Edition):

Ball, Patrick. “Identification and testing of enzymes and prodrugs for use in directed enzyme prodrug therapy strategies for the treatment of cancer.” 2019. Doctoral Dissertation, Bangor University. Accessed April 11, 2021. https://research.bangor.ac.uk/portal/en/theses/identification-and-testing-of-enzymes-and-prodrugs-for-use-in-directed-enzyme-prodrug-therapy-strategies-for-the-treatment-of-cancer(c07f9470-fc01-4ef9-8e23-426f320c3abd).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.793161.

MLA Handbook (7th Edition):

Ball, Patrick. “Identification and testing of enzymes and prodrugs for use in directed enzyme prodrug therapy strategies for the treatment of cancer.” 2019. Web. 11 Apr 2021.

Vancouver:

Ball P. Identification and testing of enzymes and prodrugs for use in directed enzyme prodrug therapy strategies for the treatment of cancer. [Internet] [Doctoral dissertation]. Bangor University; 2019. [cited 2021 Apr 11]. Available from: https://research.bangor.ac.uk/portal/en/theses/identification-and-testing-of-enzymes-and-prodrugs-for-use-in-directed-enzyme-prodrug-therapy-strategies-for-the-treatment-of-cancer(c07f9470-fc01-4ef9-8e23-426f320c3abd).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.793161.

Council of Science Editors:

Ball P. Identification and testing of enzymes and prodrugs for use in directed enzyme prodrug therapy strategies for the treatment of cancer. [Doctoral Dissertation]. Bangor University; 2019. Available from: https://research.bangor.ac.uk/portal/en/theses/identification-and-testing-of-enzymes-and-prodrugs-for-use-in-directed-enzyme-prodrug-therapy-strategies-for-the-treatment-of-cancer(c07f9470-fc01-4ef9-8e23-426f320c3abd).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.793161


University of Sydney

12. Chen, Catherine. The Design and Synthesis of Stabilised Cis- and Trans-Platinum (IV) Complexes for Targeted Drug Delivery .

Degree: 2016, University of Sydney

 Platinum(IV) complexes are a promising class of pro-drugs which may bypass the problems associated with their platinum(II) counterparts, such as cisplatin and oxaliplatin. However, any… (more)

Subjects/Keywords: platinum; drug design; cancer; tumour; prodrug; chemotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, C. (2016). The Design and Synthesis of Stabilised Cis- and Trans-Platinum (IV) Complexes for Targeted Drug Delivery . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/16513

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chen, Catherine. “The Design and Synthesis of Stabilised Cis- and Trans-Platinum (IV) Complexes for Targeted Drug Delivery .” 2016. Thesis, University of Sydney. Accessed April 11, 2021. http://hdl.handle.net/2123/16513.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chen, Catherine. “The Design and Synthesis of Stabilised Cis- and Trans-Platinum (IV) Complexes for Targeted Drug Delivery .” 2016. Web. 11 Apr 2021.

Vancouver:

Chen C. The Design and Synthesis of Stabilised Cis- and Trans-Platinum (IV) Complexes for Targeted Drug Delivery . [Internet] [Thesis]. University of Sydney; 2016. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/2123/16513.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chen C. The Design and Synthesis of Stabilised Cis- and Trans-Platinum (IV) Complexes for Targeted Drug Delivery . [Thesis]. University of Sydney; 2016. Available from: http://hdl.handle.net/2123/16513

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Vienna

13. Bielec, Björn. Entwicklung neuer Prodrug-Strategien für die Krebstherapie.

Degree: 2015, University of Vienna

Trotz großer Fortschritte in der Entwicklung von Krebstherapeutika in den letzten Jahrzehnten, leiden viele Patienten nach wie vor unter drastischen Nebenwirkungen. Eine Möglichkeit die Nebenwirkungen… (more)

Subjects/Keywords: 35.79 Biochemie: Sonstiges; 35.50 Organische Chemie: Allgemeines; 35.62 Aminosäuren, Peptide, Eiweiße; 35.52 Präparative Organische Chemie; Prodrug-Design / Prodrug / Cathepsin / Cathepsin K / Trigger / selektive Triggereinheit / Crizotinib / Crizotinib-Prodrug; prodrug design / prodrug / cathepsin / cathepsin K / trigger / selective trigger moiety / crizotinib / crizotinib prodrug

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bielec, B. (2015). Entwicklung neuer Prodrug-Strategien für die Krebstherapie. (Thesis). University of Vienna. Retrieved from http://othes.univie.ac.at/39218/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bielec, Björn. “Entwicklung neuer Prodrug-Strategien für die Krebstherapie.” 2015. Thesis, University of Vienna. Accessed April 11, 2021. http://othes.univie.ac.at/39218/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bielec, Björn. “Entwicklung neuer Prodrug-Strategien für die Krebstherapie.” 2015. Web. 11 Apr 2021.

Vancouver:

Bielec B. Entwicklung neuer Prodrug-Strategien für die Krebstherapie. [Internet] [Thesis]. University of Vienna; 2015. [cited 2021 Apr 11]. Available from: http://othes.univie.ac.at/39218/.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bielec B. Entwicklung neuer Prodrug-Strategien für die Krebstherapie. [Thesis]. University of Vienna; 2015. Available from: http://othes.univie.ac.at/39218/

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New Mexico

14. Cao, Yanting. Development of Novel Small Molecules for Imaging and Drug Release.

Degree: Department of Chemistry and Chemical Biology, 2014, University of New Mexico

 Small organic molecules, including small molecule based fluorescent probes, small molecule based drugs or prodrugs, and smart multifunctional fluorescent drug delivery systems play important roles… (more)

Subjects/Keywords: anticancer prodrug; DNA cross-linking; drug delivery system; drug release; fluorescent imaging; fluorescent probe; mechlorethamine; multiple drugs delivery; multiplexing recognitions; photo-activated prodrug; prodrug

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cao, Y. (2014). Development of Novel Small Molecules for Imaging and Drug Release. (Doctoral Dissertation). University of New Mexico. Retrieved from https://digitalrepository.unm.edu/chem_etds/36

Chicago Manual of Style (16th Edition):

Cao, Yanting. “Development of Novel Small Molecules for Imaging and Drug Release.” 2014. Doctoral Dissertation, University of New Mexico. Accessed April 11, 2021. https://digitalrepository.unm.edu/chem_etds/36.

MLA Handbook (7th Edition):

Cao, Yanting. “Development of Novel Small Molecules for Imaging and Drug Release.” 2014. Web. 11 Apr 2021.

Vancouver:

Cao Y. Development of Novel Small Molecules for Imaging and Drug Release. [Internet] [Doctoral dissertation]. University of New Mexico; 2014. [cited 2021 Apr 11]. Available from: https://digitalrepository.unm.edu/chem_etds/36.

Council of Science Editors:

Cao Y. Development of Novel Small Molecules for Imaging and Drug Release. [Doctoral Dissertation]. University of New Mexico; 2014. Available from: https://digitalrepository.unm.edu/chem_etds/36

15. Aribi, Fallia. Development and biological evaluation of novel fluorinated ingredients for modern crop protection : Développement et évaluation biologique de nouveaux ingrédients fluorés pour une protection moderne des cultures.

Degree: Docteur es, Chimie organique, 2017, Université de Strasbourg

Ce doctorat a permis la conception de nouvelles molécules destinées aux développements de futurs produits phytosanitaires. Tout d’abord, la synthèse d’alpha,alpha-difluoro-beta-hydroxy cétones a été réalisée.… (more)

Subjects/Keywords: GABA; Agonistes; Prodrug; Quinoléines; FAR; Fluor; Hétérocyles; Synthèse; GABA; Agonists; Prodrug; Quinolines; FAR; Fluor; Heterocycles; Synthesis; 547.2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aribi, F. (2017). Development and biological evaluation of novel fluorinated ingredients for modern crop protection : Développement et évaluation biologique de nouveaux ingrédients fluorés pour une protection moderne des cultures. (Doctoral Dissertation). Université de Strasbourg. Retrieved from http://www.theses.fr/2017STRAF020

Chicago Manual of Style (16th Edition):

Aribi, Fallia. “Development and biological evaluation of novel fluorinated ingredients for modern crop protection : Développement et évaluation biologique de nouveaux ingrédients fluorés pour une protection moderne des cultures.” 2017. Doctoral Dissertation, Université de Strasbourg. Accessed April 11, 2021. http://www.theses.fr/2017STRAF020.

MLA Handbook (7th Edition):

Aribi, Fallia. “Development and biological evaluation of novel fluorinated ingredients for modern crop protection : Développement et évaluation biologique de nouveaux ingrédients fluorés pour une protection moderne des cultures.” 2017. Web. 11 Apr 2021.

Vancouver:

Aribi F. Development and biological evaluation of novel fluorinated ingredients for modern crop protection : Développement et évaluation biologique de nouveaux ingrédients fluorés pour une protection moderne des cultures. [Internet] [Doctoral dissertation]. Université de Strasbourg; 2017. [cited 2021 Apr 11]. Available from: http://www.theses.fr/2017STRAF020.

Council of Science Editors:

Aribi F. Development and biological evaluation of novel fluorinated ingredients for modern crop protection : Développement et évaluation biologique de nouveaux ingrédients fluorés pour une protection moderne des cultures. [Doctoral Dissertation]. Université de Strasbourg; 2017. Available from: http://www.theses.fr/2017STRAF020

16. 古澤, 美麗. 細胞内生命現象の制御を指向した刺激応答性核酸の合成と応用.

Degree: Japan Advanced Institute of Science and Technology / 北陸先端科学技術大学院大学

Supervisor:藤本健造

マテリアルサイエンス研究科

修士

Subjects/Keywords: 5-Fluorouracil; Prodrug; Photoirradiation; Oligonucleotide

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

古澤, . (n.d.). 細胞内生命現象の制御を指向した刺激応答性核酸の合成と応用. (Thesis). Japan Advanced Institute of Science and Technology / 北陸先端科学技術大学院大学. Retrieved from http://hdl.handle.net/10119/12723

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

古澤, 美麗. “細胞内生命現象の制御を指向した刺激応答性核酸の合成と応用.” Thesis, Japan Advanced Institute of Science and Technology / 北陸先端科学技術大学院大学. Accessed April 11, 2021. http://hdl.handle.net/10119/12723.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

古澤, 美麗. “細胞内生命現象の制御を指向した刺激応答性核酸の合成と応用.” Web. 11 Apr 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

古澤 . 細胞内生命現象の制御を指向した刺激応答性核酸の合成と応用. [Internet] [Thesis]. Japan Advanced Institute of Science and Technology / 北陸先端科学技術大学院大学; [cited 2021 Apr 11]. Available from: http://hdl.handle.net/10119/12723.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

古澤 . 細胞内生命現象の制御を指向した刺激応答性核酸の合成と応用. [Thesis]. Japan Advanced Institute of Science and Technology / 北陸先端科学技術大学院大学; Available from: http://hdl.handle.net/10119/12723

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of California – San Diego

17. Perez, Christian. Esterase and reactive-oxygen species (ROS)-activated prodrug strategies.

Degree: Chemistry, 2015, University of California – San Diego

 Prodrugs are derivatives of bioactive molecules that can become activated in vivo by a chemical or enzymatic stimulus. They serve as tools to help improve… (more)

Subjects/Keywords: Chemistry; Esterase; Metalloenzyme; Prodrug; Reactive Oxygen Species; ROS; Thiazolidinone

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Perez, C. (2015). Esterase and reactive-oxygen species (ROS)-activated prodrug strategies. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/8rh8n8sb

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Perez, Christian. “Esterase and reactive-oxygen species (ROS)-activated prodrug strategies.” 2015. Thesis, University of California – San Diego. Accessed April 11, 2021. http://www.escholarship.org/uc/item/8rh8n8sb.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Perez, Christian. “Esterase and reactive-oxygen species (ROS)-activated prodrug strategies.” 2015. Web. 11 Apr 2021.

Vancouver:

Perez C. Esterase and reactive-oxygen species (ROS)-activated prodrug strategies. [Internet] [Thesis]. University of California – San Diego; 2015. [cited 2021 Apr 11]. Available from: http://www.escholarship.org/uc/item/8rh8n8sb.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Perez C. Esterase and reactive-oxygen species (ROS)-activated prodrug strategies. [Thesis]. University of California – San Diego; 2015. Available from: http://www.escholarship.org/uc/item/8rh8n8sb

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

18. Li, Shui. Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity.

Degree: 2012, University of Minnesota

University of Minnesota M.S. thesis. August 2012. Major: Medicinal Chemistry. Advisors:Dr. Patrick Hanna, Dr. Carston Wagner. 1 computer file (PDF); vi, 95 pages.

The development… (more)

Subjects/Keywords: Chemosensitization; eIF4E; Eukaryotic translation initiation; Intracellular detection; Phosphoramidate; Prodrug

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Li, S. (2012). Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity. (Masters Thesis). University of Minnesota. Retrieved from http://purl.umn.edu/140071

Chicago Manual of Style (16th Edition):

Li, Shui. “Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity.” 2012. Masters Thesis, University of Minnesota. Accessed April 11, 2021. http://purl.umn.edu/140071.

MLA Handbook (7th Edition):

Li, Shui. “Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity.” 2012. Web. 11 Apr 2021.

Vancouver:

Li S. Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity. [Internet] [Masters thesis]. University of Minnesota; 2012. [cited 2021 Apr 11]. Available from: http://purl.umn.edu/140071.

Council of Science Editors:

Li S. Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity. [Masters Thesis]. University of Minnesota; 2012. Available from: http://purl.umn.edu/140071

19. Nemdeo, Kamta Prasad. Synthesis of some new derivatives: a Redox delivery prodrug approach for brain specific sustained release; -.

Degree: Chemistry, 2013, Bundelkhand University

None

Summary p. 206-213, References 214p.

Advisors/Committee Members: Shrivastava, S K, Chandra, Ramesh.

Subjects/Keywords: Chemistry; Redox delivery prodrug

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nemdeo, K. P. (2013). Synthesis of some new derivatives: a Redox delivery prodrug approach for brain specific sustained release; -. (Thesis). Bundelkhand University. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/10814

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Nemdeo, Kamta Prasad. “Synthesis of some new derivatives: a Redox delivery prodrug approach for brain specific sustained release; -.” 2013. Thesis, Bundelkhand University. Accessed April 11, 2021. http://shodhganga.inflibnet.ac.in/handle/10603/10814.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Nemdeo, Kamta Prasad. “Synthesis of some new derivatives: a Redox delivery prodrug approach for brain specific sustained release; -.” 2013. Web. 11 Apr 2021.

Vancouver:

Nemdeo KP. Synthesis of some new derivatives: a Redox delivery prodrug approach for brain specific sustained release; -. [Internet] [Thesis]. Bundelkhand University; 2013. [cited 2021 Apr 11]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/10814.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nemdeo KP. Synthesis of some new derivatives: a Redox delivery prodrug approach for brain specific sustained release; -. [Thesis]. Bundelkhand University; 2013. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/10814

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

20. Bordat, Alexandre. Stratégies alternatives pour la délivrance d'anticancéreux par encapsulation physique dans des nanoparticules polymère thermosensibles ou par couplage chimique en prodrogues polymères : Alternative strategies for the delivery of anticancer drugs by physical encapsulation in thermoresponsive polymer nanoparticles or chemical coupling as polymer prodrugs.

Degree: Docteur es, Pharmacotechnie et biopharmacie, 2018, Université Paris-Saclay (ComUE)

Cette thèse s’articule autour de systèmes innovants de délivrance d’anticancéreux pour répondre aux limitations actuelles des systèmes de type nanoparticules. Celles-ci permettent l’encapsulation d’anticancéreux pour… (more)

Subjects/Keywords: Nanoparticule; Thermosensible; Anticancéreux; Prodrogue; Polymère; Nanoparticles; Thermoresponsive; Anti-Cancer; Prodrug; Polymer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bordat, A. (2018). Stratégies alternatives pour la délivrance d'anticancéreux par encapsulation physique dans des nanoparticules polymère thermosensibles ou par couplage chimique en prodrogues polymères : Alternative strategies for the delivery of anticancer drugs by physical encapsulation in thermoresponsive polymer nanoparticles or chemical coupling as polymer prodrugs. (Doctoral Dissertation). Université Paris-Saclay (ComUE). Retrieved from http://www.theses.fr/2018SACLS595

Chicago Manual of Style (16th Edition):

Bordat, Alexandre. “Stratégies alternatives pour la délivrance d'anticancéreux par encapsulation physique dans des nanoparticules polymère thermosensibles ou par couplage chimique en prodrogues polymères : Alternative strategies for the delivery of anticancer drugs by physical encapsulation in thermoresponsive polymer nanoparticles or chemical coupling as polymer prodrugs.” 2018. Doctoral Dissertation, Université Paris-Saclay (ComUE). Accessed April 11, 2021. http://www.theses.fr/2018SACLS595.

MLA Handbook (7th Edition):

Bordat, Alexandre. “Stratégies alternatives pour la délivrance d'anticancéreux par encapsulation physique dans des nanoparticules polymère thermosensibles ou par couplage chimique en prodrogues polymères : Alternative strategies for the delivery of anticancer drugs by physical encapsulation in thermoresponsive polymer nanoparticles or chemical coupling as polymer prodrugs.” 2018. Web. 11 Apr 2021.

Vancouver:

Bordat A. Stratégies alternatives pour la délivrance d'anticancéreux par encapsulation physique dans des nanoparticules polymère thermosensibles ou par couplage chimique en prodrogues polymères : Alternative strategies for the delivery of anticancer drugs by physical encapsulation in thermoresponsive polymer nanoparticles or chemical coupling as polymer prodrugs. [Internet] [Doctoral dissertation]. Université Paris-Saclay (ComUE); 2018. [cited 2021 Apr 11]. Available from: http://www.theses.fr/2018SACLS595.

Council of Science Editors:

Bordat A. Stratégies alternatives pour la délivrance d'anticancéreux par encapsulation physique dans des nanoparticules polymère thermosensibles ou par couplage chimique en prodrogues polymères : Alternative strategies for the delivery of anticancer drugs by physical encapsulation in thermoresponsive polymer nanoparticles or chemical coupling as polymer prodrugs. [Doctoral Dissertation]. Université Paris-Saclay (ComUE); 2018. Available from: http://www.theses.fr/2018SACLS595


Central Connecticut State University

21. Barboni, Paul, 1974-. Development of an enzyme linked immunosorbant assay for quantitative detection of murine anti-human antibodies / Paul Barboni.

Degree: Department of Biomolecular Sciences, 2004, Central Connecticut State University

 During the development of potential protein or antibody therapeutics in a pharmaceutical environment, the use of animal models as test subjects is a necessary requirement.… (more)

Subjects/Keywords: Antibody-directed enzyme prodrug therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Barboni, Paul, 1. (2004). Development of an enzyme linked immunosorbant assay for quantitative detection of murine anti-human antibodies / Paul Barboni. (Thesis). Central Connecticut State University. Retrieved from http://content.library.ccsu.edu/u?/ccsutheses,1463

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Barboni, Paul, 1974-. “Development of an enzyme linked immunosorbant assay for quantitative detection of murine anti-human antibodies / Paul Barboni.” 2004. Thesis, Central Connecticut State University. Accessed April 11, 2021. http://content.library.ccsu.edu/u?/ccsutheses,1463.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Barboni, Paul, 1974-. “Development of an enzyme linked immunosorbant assay for quantitative detection of murine anti-human antibodies / Paul Barboni.” 2004. Web. 11 Apr 2021.

Vancouver:

Barboni, Paul 1. Development of an enzyme linked immunosorbant assay for quantitative detection of murine anti-human antibodies / Paul Barboni. [Internet] [Thesis]. Central Connecticut State University; 2004. [cited 2021 Apr 11]. Available from: http://content.library.ccsu.edu/u?/ccsutheses,1463.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Barboni, Paul 1. Development of an enzyme linked immunosorbant assay for quantitative detection of murine anti-human antibodies / Paul Barboni. [Thesis]. Central Connecticut State University; 2004. Available from: http://content.library.ccsu.edu/u?/ccsutheses,1463

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manchester

22. Song, Yiwei. Synthesis and evaluation of novel alpha-oxyalkyl-alpha,beta-cyclohexenones as pro-drugs for the intracellular delivery of inhibitors of the oxidoreductase enzyme NQO1.

Degree: PhD, 2018, University of Manchester

 The alpha-oxymethyl-alpha,beta-cyclohexenone moiety is embedded in several bioactive natural products, including 2-crotonyloxymethyl-(4R,5R,6R)-4,5,6-trihydroxycyclohex-2-enone (COTC) and the terpenoid, antheminone A. Both compounds exhibit cytotoxicity towards a variety… (more)

Subjects/Keywords: 540; NQO1; organic synthesis; medicinal chemistry; anticancer prodrug

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Song, Y. (2018). Synthesis and evaluation of novel alpha-oxyalkyl-alpha,beta-cyclohexenones as pro-drugs for the intracellular delivery of inhibitors of the oxidoreductase enzyme NQO1. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/synthesis-and-evaluation-of-novel-alphaoxyalkylalphabetacyclohexenones-as-prodrugs-for-the-intracellular-delivery-of-inhibitors-of-the-oxidoreductase-enzyme-nqo1(95e9a037-1418-4015-95eb-22bd85ea2fed).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771355

Chicago Manual of Style (16th Edition):

Song, Yiwei. “Synthesis and evaluation of novel alpha-oxyalkyl-alpha,beta-cyclohexenones as pro-drugs for the intracellular delivery of inhibitors of the oxidoreductase enzyme NQO1.” 2018. Doctoral Dissertation, University of Manchester. Accessed April 11, 2021. https://www.research.manchester.ac.uk/portal/en/theses/synthesis-and-evaluation-of-novel-alphaoxyalkylalphabetacyclohexenones-as-prodrugs-for-the-intracellular-delivery-of-inhibitors-of-the-oxidoreductase-enzyme-nqo1(95e9a037-1418-4015-95eb-22bd85ea2fed).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771355.

MLA Handbook (7th Edition):

Song, Yiwei. “Synthesis and evaluation of novel alpha-oxyalkyl-alpha,beta-cyclohexenones as pro-drugs for the intracellular delivery of inhibitors of the oxidoreductase enzyme NQO1.” 2018. Web. 11 Apr 2021.

Vancouver:

Song Y. Synthesis and evaluation of novel alpha-oxyalkyl-alpha,beta-cyclohexenones as pro-drugs for the intracellular delivery of inhibitors of the oxidoreductase enzyme NQO1. [Internet] [Doctoral dissertation]. University of Manchester; 2018. [cited 2021 Apr 11]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/synthesis-and-evaluation-of-novel-alphaoxyalkylalphabetacyclohexenones-as-prodrugs-for-the-intracellular-delivery-of-inhibitors-of-the-oxidoreductase-enzyme-nqo1(95e9a037-1418-4015-95eb-22bd85ea2fed).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771355.

Council of Science Editors:

Song Y. Synthesis and evaluation of novel alpha-oxyalkyl-alpha,beta-cyclohexenones as pro-drugs for the intracellular delivery of inhibitors of the oxidoreductase enzyme NQO1. [Doctoral Dissertation]. University of Manchester; 2018. Available from: https://www.research.manchester.ac.uk/portal/en/theses/synthesis-and-evaluation-of-novel-alphaoxyalkylalphabetacyclohexenones-as-prodrugs-for-the-intracellular-delivery-of-inhibitors-of-the-oxidoreductase-enzyme-nqo1(95e9a037-1418-4015-95eb-22bd85ea2fed).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771355


University of Washington

23. Kelly, Abby M. Inhalable antibiotic prodrug therapies for the treatment of intracellular pulmonary infections.

Degree: 2018, University of Washington

 One hundred years after the discovery of antimicrobials and antibiotics, lower respiratory infections remain one of the leading causes of death worldwide. Infectious agents such… (more)

Subjects/Keywords: Drug Delivery; Infection; Inhalable therapies; Meropenem; Prodrug; RAFT polymerization; Bioengineering; Bioengineering

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kelly, A. M. (2018). Inhalable antibiotic prodrug therapies for the treatment of intracellular pulmonary infections. (Thesis). University of Washington. Retrieved from http://hdl.handle.net/1773/40845

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kelly, Abby M. “Inhalable antibiotic prodrug therapies for the treatment of intracellular pulmonary infections.” 2018. Thesis, University of Washington. Accessed April 11, 2021. http://hdl.handle.net/1773/40845.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kelly, Abby M. “Inhalable antibiotic prodrug therapies for the treatment of intracellular pulmonary infections.” 2018. Web. 11 Apr 2021.

Vancouver:

Kelly AM. Inhalable antibiotic prodrug therapies for the treatment of intracellular pulmonary infections. [Internet] [Thesis]. University of Washington; 2018. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/1773/40845.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kelly AM. Inhalable antibiotic prodrug therapies for the treatment of intracellular pulmonary infections. [Thesis]. University of Washington; 2018. Available from: http://hdl.handle.net/1773/40845

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

24. Scarbrough, Emily Desiree. Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor.

Degree: 2015, University of Nevada – Reno

 Cyclotriazadisulfonamide (CADA) inhibits HIV replication by selectively down-modulating expression of the CD4 receptor protein on host cells. Current studies are aimed at developing a prodrug(more)

Subjects/Keywords: 11 membered ring; anti-HIV; aziridine; CADA; CD4 Receptor; Prodrug

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Scarbrough, E. D. (2015). Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor. (Thesis). University of Nevada – Reno. Retrieved from http://hdl.handle.net/11714/2623

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Scarbrough, Emily Desiree. “Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor.” 2015. Thesis, University of Nevada – Reno. Accessed April 11, 2021. http://hdl.handle.net/11714/2623.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Scarbrough, Emily Desiree. “Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor.” 2015. Web. 11 Apr 2021.

Vancouver:

Scarbrough ED. Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor. [Internet] [Thesis]. University of Nevada – Reno; 2015. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/11714/2623.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Scarbrough ED. Synthesis of Novel CADA Analog Prodrugs and Ring-Size Variants Designed to Act as anti-HIV Agents via Down-Modulation of the CD4 Receptor. [Thesis]. University of Nevada – Reno; 2015. Available from: http://hdl.handle.net/11714/2623

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


East Tennessee State University

25. McGoldrick, Christopher Allen. Novel Ester Substrates for the Detection and Treatment of Prostate Cancer.

Degree: PhD, Biomedical Sciences, 2013, East Tennessee State University

  Cancer cell esterases are often overexpressed and some have chiral specificities different from those of corresponding normal cells. Carboxylesterases in particular are known to… (more)

Subjects/Keywords: oxidized protein hydrolase; prodrug; carboxylesterase; prostate cancer; molecular beacon; Biochemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McGoldrick, C. A. (2013). Novel Ester Substrates for the Detection and Treatment of Prostate Cancer. (Doctoral Dissertation). East Tennessee State University. Retrieved from https://dc.etsu.edu/etd/2308

Chicago Manual of Style (16th Edition):

McGoldrick, Christopher Allen. “Novel Ester Substrates for the Detection and Treatment of Prostate Cancer.” 2013. Doctoral Dissertation, East Tennessee State University. Accessed April 11, 2021. https://dc.etsu.edu/etd/2308.

MLA Handbook (7th Edition):

McGoldrick, Christopher Allen. “Novel Ester Substrates for the Detection and Treatment of Prostate Cancer.” 2013. Web. 11 Apr 2021.

Vancouver:

McGoldrick CA. Novel Ester Substrates for the Detection and Treatment of Prostate Cancer. [Internet] [Doctoral dissertation]. East Tennessee State University; 2013. [cited 2021 Apr 11]. Available from: https://dc.etsu.edu/etd/2308.

Council of Science Editors:

McGoldrick CA. Novel Ester Substrates for the Detection and Treatment of Prostate Cancer. [Doctoral Dissertation]. East Tennessee State University; 2013. Available from: https://dc.etsu.edu/etd/2308


University of Minnesota

26. Li, Shui. Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity.

Degree: MS, Medicinal Chemistry, 2012, University of Minnesota

 The development of cancer and fibrotic diseases has been shown to be highly dependent on disregulation of cap-dependent translation. Binding protein eIF4E to N7-methylated guanosine… (more)

Subjects/Keywords: Chemosensitization; eIF4E; Eukaryotic translation initiation; Intracellular detection; Phosphoramidate; Prodrug

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Li, S. (2012). Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity. (Masters Thesis). University of Minnesota. Retrieved from http://purl.umn.edu/140071

Chicago Manual of Style (16th Edition):

Li, Shui. “Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity.” 2012. Masters Thesis, University of Minnesota. Accessed April 11, 2021. http://purl.umn.edu/140071.

MLA Handbook (7th Edition):

Li, Shui. “Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity.” 2012. Web. 11 Apr 2021.

Vancouver:

Li S. Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity. [Internet] [Masters thesis]. University of Minnesota; 2012. [cited 2021 Apr 11]. Available from: http://purl.umn.edu/140071.

Council of Science Editors:

Li S. Evaluation of Eukaryotic Initiation Factor 4E (eIF4E) antagonist 4Ei-1 in mammalian breast cancer and lung cancer cells : chemosensitizaiton with low cytotoxicity. [Masters Thesis]. University of Minnesota; 2012. Available from: http://purl.umn.edu/140071


University of Minnesota

27. Wohl, Adam Richard. Synthesis and characterization of silicate ester prodrugs and poly(ethylene glycol)-b-poly(lactic-co-glycolic acid) block copolymers for formulation into prodrug-loaded nanoparticles.

Degree: PhD, Chemistry, 2012, University of Minnesota

 Fine control of the physical and chemical properties of customized materials is a field that is rapidly advancing. This is especially critical in pursuits to… (more)

Subjects/Keywords: Block copolymer; Flash nanoprecipitation; Prodrug; Silicate ester; Chemistry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wohl, A. R. (2012). Synthesis and characterization of silicate ester prodrugs and poly(ethylene glycol)-b-poly(lactic-co-glycolic acid) block copolymers for formulation into prodrug-loaded nanoparticles. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/167686

Chicago Manual of Style (16th Edition):

Wohl, Adam Richard. “Synthesis and characterization of silicate ester prodrugs and poly(ethylene glycol)-b-poly(lactic-co-glycolic acid) block copolymers for formulation into prodrug-loaded nanoparticles.” 2012. Doctoral Dissertation, University of Minnesota. Accessed April 11, 2021. http://hdl.handle.net/11299/167686.

MLA Handbook (7th Edition):

Wohl, Adam Richard. “Synthesis and characterization of silicate ester prodrugs and poly(ethylene glycol)-b-poly(lactic-co-glycolic acid) block copolymers for formulation into prodrug-loaded nanoparticles.” 2012. Web. 11 Apr 2021.

Vancouver:

Wohl AR. Synthesis and characterization of silicate ester prodrugs and poly(ethylene glycol)-b-poly(lactic-co-glycolic acid) block copolymers for formulation into prodrug-loaded nanoparticles. [Internet] [Doctoral dissertation]. University of Minnesota; 2012. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/11299/167686.

Council of Science Editors:

Wohl AR. Synthesis and characterization of silicate ester prodrugs and poly(ethylene glycol)-b-poly(lactic-co-glycolic acid) block copolymers for formulation into prodrug-loaded nanoparticles. [Doctoral Dissertation]. University of Minnesota; 2012. Available from: http://hdl.handle.net/11299/167686


University of Minnesota

28. Maize, Kimberly. Structural Biology for Drug Design: Applications in Two Systems.

Degree: PhD, Medicinal Chemistry, 2016, University of Minnesota

 Two projects comprise this dissertation; both are focused on using the technique of protein X-ray crystallography to understand the molecular interactions that small molecules make… (more)

Subjects/Keywords: anthrax; crystallography; HINT; Lethal Factor; prodrug; Structure-based drug design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maize, K. (2016). Structural Biology for Drug Design: Applications in Two Systems. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/182796

Chicago Manual of Style (16th Edition):

Maize, Kimberly. “Structural Biology for Drug Design: Applications in Two Systems.” 2016. Doctoral Dissertation, University of Minnesota. Accessed April 11, 2021. http://hdl.handle.net/11299/182796.

MLA Handbook (7th Edition):

Maize, Kimberly. “Structural Biology for Drug Design: Applications in Two Systems.” 2016. Web. 11 Apr 2021.

Vancouver:

Maize K. Structural Biology for Drug Design: Applications in Two Systems. [Internet] [Doctoral dissertation]. University of Minnesota; 2016. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/11299/182796.

Council of Science Editors:

Maize K. Structural Biology for Drug Design: Applications in Two Systems. [Doctoral Dissertation]. University of Minnesota; 2016. Available from: http://hdl.handle.net/11299/182796


University of Southern California

29. Wang, Yan. Proinsulin-transferrin recombinant fusion protein: mechanism of activation and potential application in diabetes treatment.

Degree: PhD, Molecular Pharmacology and Toxicology, 2013, University of Southern California

 Long-acting insulin (INS) analogues that exhibit prolonged time-action profiles and liver-specificity are currently in great demand for diabetes treatment. Native INS and its protein precursor… (more)

Subjects/Keywords: transferrin; insulin; proinsulin; prodrug activation; recombinant fusion protein; diabetes

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, Y. (2013). Proinsulin-transferrin recombinant fusion protein: mechanism of activation and potential application in diabetes treatment. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/91307/rec/5274

Chicago Manual of Style (16th Edition):

Wang, Yan. “Proinsulin-transferrin recombinant fusion protein: mechanism of activation and potential application in diabetes treatment.” 2013. Doctoral Dissertation, University of Southern California. Accessed April 11, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/91307/rec/5274.

MLA Handbook (7th Edition):

Wang, Yan. “Proinsulin-transferrin recombinant fusion protein: mechanism of activation and potential application in diabetes treatment.” 2013. Web. 11 Apr 2021.

Vancouver:

Wang Y. Proinsulin-transferrin recombinant fusion protein: mechanism of activation and potential application in diabetes treatment. [Internet] [Doctoral dissertation]. University of Southern California; 2013. [cited 2021 Apr 11]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/91307/rec/5274.

Council of Science Editors:

Wang Y. Proinsulin-transferrin recombinant fusion protein: mechanism of activation and potential application in diabetes treatment. [Doctoral Dissertation]. University of Southern California; 2013. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/91307/rec/5274


University of Minnesota

30. Okon, Aniekan. Development of chemical probes for intracellular nucleotide delivery, profiling of the metabolic fate(s) of nucleoside monoester phosphoramidates, and a nucleotide mimetic inhibitor of eIF4E.

Degree: PhD, Medicinal Chemistry, 2018, University of Minnesota

 Significant progress has been made towards the development of phosphate prodrugs for intracellular delivery of monophosphates. Such efforts led to the successful application of the… (more)

Subjects/Keywords: Nucleotide mimetic; Phosphoramidate; Photoaffinity probes; Prodrug; Pronucleotide; Translational Control

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Okon, A. (2018). Development of chemical probes for intracellular nucleotide delivery, profiling of the metabolic fate(s) of nucleoside monoester phosphoramidates, and a nucleotide mimetic inhibitor of eIF4E. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/216354

Chicago Manual of Style (16th Edition):

Okon, Aniekan. “Development of chemical probes for intracellular nucleotide delivery, profiling of the metabolic fate(s) of nucleoside monoester phosphoramidates, and a nucleotide mimetic inhibitor of eIF4E.” 2018. Doctoral Dissertation, University of Minnesota. Accessed April 11, 2021. http://hdl.handle.net/11299/216354.

MLA Handbook (7th Edition):

Okon, Aniekan. “Development of chemical probes for intracellular nucleotide delivery, profiling of the metabolic fate(s) of nucleoside monoester phosphoramidates, and a nucleotide mimetic inhibitor of eIF4E.” 2018. Web. 11 Apr 2021.

Vancouver:

Okon A. Development of chemical probes for intracellular nucleotide delivery, profiling of the metabolic fate(s) of nucleoside monoester phosphoramidates, and a nucleotide mimetic inhibitor of eIF4E. [Internet] [Doctoral dissertation]. University of Minnesota; 2018. [cited 2021 Apr 11]. Available from: http://hdl.handle.net/11299/216354.

Council of Science Editors:

Okon A. Development of chemical probes for intracellular nucleotide delivery, profiling of the metabolic fate(s) of nucleoside monoester phosphoramidates, and a nucleotide mimetic inhibitor of eIF4E. [Doctoral Dissertation]. University of Minnesota; 2018. Available from: http://hdl.handle.net/11299/216354

[1] [2] [3] [4] [5]

.